The current financial score of Ainos Inc is 4.69. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 152.00, representing a year-over-year decrease of 96.74%, while its net profit experienced a year-over-year decrease of 12.48%.
The current valuation score of Ainos Inc is 7.76. Its current P/E ratio is -0.50, which is -70.87% below the recent high of -0.15 and -247.12% above the recent low of -1.73.
No earnings forecast score is currently available for Ainos Inc. The Biotechnology & Medical Research industry's average is 8.11.
The current price momentum score of Ainos Inc is 4.17. Currently, the stock price is trading between the resistance level at 1.61 and the support level at 1.28, making it suitable for range-bound swing trading.
The current institutional shareholding score of Ainos Inc is 3.00. The latest institutional shareholding proportion is 4.13%, representing a quarter-over-quarter increase of 525.97%.
The current risk assessment score of Ainos Inc is 2.32. The company's beta value is 2.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.